No Data
No Data
Lumos Diagnostics Receives $400,000 in Milestone Payment From Hologic; Shares Up 3%
Lumos Diagnostics Holdings (ASX:LDX) received $400,000 in milestone payment from women's health company Hologic as part of a development agreement announced in January, according to a Wednesday filing
Lumos Diagnostics Secures Additional US$5m for Pioneering Pre-term Birth Test Development
Lumos Diagnostics (ASX: LDX) has received a second US$5 million payment from women’s health firm Hologic Inc under an intellectual property (IP) agreement signed between the two companies in January.
Lumos Diagnostics Receives Second Payment Under IP Agreement; Shares Up 8%
Lumos Diagnostics (ASX:LDX) received the second payment of $5.0 million from Hologic under an intellectual property agreement disclosed in January. This brought the total payments received under the a
Lumos Diagnostics Concludes Initial Phase of Development Deal With Hologic for Fetal Fibronectin Test; Shares Jump 6%
Lumos Diagnostics (ASX:LDX) concluded the initial stage of its development agreement, aimed at creating a novel fetal fibronectin (fFN) test for women's health company Hologic, according to a Monday f
Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children With Febrile Respiratory Infections, Study Shows
International journal Infectious Diseases and Clinical Microbiology has published results of Lumos Diagnostics Holdings' (ASX:LDX) FebriDx study in 216 pediatric patients, according to a Monday Austra
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%
Lumos Diagnostics (ASX:LDX) hired Nasdaq-listed medical supply firm Henry Schein as the US distributor for its FebriDx blood-based respiratory infection diagnostic test. Henry Schein is currently dist
No Data